Join JMI Labs, proud to be part of ÌìÃÀ´«Ã½, at ASM/ESCMID 2023 from September 19-22, 2023 in Boston, MA.
We're thrilled JMI Labs is part of ÌìÃÀ´«Ã½! We're dedicated to helping you achieve your drug development goals with comprehensive, high-quality CLIA-certified reference microbiology and molecular lab services. We're committed to working with you to advance antimicrobial therapies through outstanding science - and that includes continuing to perform surveillance studies for new drug development and post-marketing monitoring of approved drugs through the SENTRY Antimicrobial Surveillance Program. Learn more about ÌìÃÀ´«Ã½'s testing services by connecting with us at ASM/ESCMID.
About the event
Co-sponsored by ASM and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will highlight the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.
Book a meeting
Schedule a meeting below with one of ÌìÃÀ´«Ã½'s experts to learn more about our comprehensive suite of full-service testing related to antimicrobial resistance.
More from ÌìÃÀ´«Ã½
Molecular Studies and Testing Services
ÌìÃÀ´«Ã½'s CLIA certified reference microbiology lab molecular studies help you achieve research and clinical goals with accurate, reliable data.Â
Microbiome Testing and Analysis
From DNA sequencing to microbiome profiling, we offer a full range of microbiome analysis services tailored to your specific needs.
 Bacterial and Fungal Phase I-IV Clinical Trial Support
Streamline research and accelerate development of new treatments. Services include study design, regulatory support, and data management.Â
JMI SENTRY Antimicrobial Surveillance Program
We're thrilled JMI Labs is part of ÌìÃÀ´«Ã½, and we continue to provide critical antimicrobial surveillance studies through the SENTRY program.